DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Glund S, Stangier J, Schmohl M. et al.
Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
Lancet 2015;
386: 680-690.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.